Patch Proves Effective Against Oral Lichen Planus in Phase 2b Study
The Rivelin Clobetasol patch (Rivelin-CLO) from AFYX Therapeutics has met the primary and secondary endpoints in a Phase 2b study in patients with.
Industry News
